Download in electronic PDF format for $25



Search the Complete Journal Archives

Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1

Author(s):  Allen Loyd V Jr

Issue:  Jan/Feb 2015 - Volume 19, Number 1
View All Articles in Issue

Abstract:  The world of pharmaceuticals is changing rapidly as biotechnology continues to grow and nanotechnology appears on the horizon. Biotechnology is gaining in importance in extemporaneous pharmaceutical compounding, and nanotechnology and pharmacogenomics could drastically change the practice of pharmacy. This article discusses biotechnology and the factors to consider when compounding biotechnology drugs.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, biotechnology, cloning, recombinant DNA, recombinant proteins, transgenic organisms, route of administration, peptides, small molecules, excipients, drug carriers

Related Categories: EXCIPIENTS, HISTORY, STABILITIES, COMPATIBILITIES, TECHNOLOGY

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1 Allen Loyd V Jr Jan/Feb 2015 38-40 Buy
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr Nov/Dec 2003 449-450 Buy
Basics of Sterile Compounding: Manipulating Peptides and Proteins Akers Michael J May/Jun 2017 223-228 Buy
Basics of Compounding: Basics of Compounding with Complex Organic Molecules Allen Loyd V Jr May/Jun 2011 234-238 Buy
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2 Allen Loyd V Jul/Aug 2015 280-287 Buy
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr Sep/Oct 2017 356 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr Nov/Dec 2015 487-488 Buy
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms Akers Michael J Jan/Feb 2017 47-56 Buy
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Allen Loyd V Jr Sep/Oct 2015 389-390 Buy